Atea Pharmaceuticals Inc
Atea Pharmaceuticals Inc
AVIR

Atea Pharmaceuticals Inc (AVIR)

$7.12.87%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$7.04
Day's Range
$7.29
$5.31
52-Week Range
$46.91
1 month return7.23%
3 month return2.96%
1 year return69.54%
5 year return75.91%

Company Information

Atea is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing therapies to address the unmet medical needs of patients with life-threatening viral diseases. Leveraging its deep understanding of antiviral drug development, nucleoside biology, and medicinal chemistry, the Company has built a proprietary purine nucleotide prodrug platform to develop novel product candidates to treat single stranded ribonucleic acid, or ssRNA, viruses, which are a prevalent cause of severe viral diseases. Currently, the Company is focused on the development of orally available, potent, and selective nucleotide prodrugs for difficult-to-treat, life-threatening viral infections, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, dengue virus, hepatitis C virus (HCV) infection, and respiratory syncytial virus (RSV).
OrganizationAtea Pharmaceuticals Inc
Employees39
CEO
IndustryHealth Technology

Analyst Recommendation

based on 11 analysts ratings

Buy
63%
Buy
27%
Hold
9%
Sell

Based on 11 Wall street analysts offering stock ratings for Atea Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 12.68%

Current

$7.1

Target

$8.0

Recommendation Trend

Based on 11 analyst

Current1M Ago3M Ago
Buy
7
7
8
Hold
3
4
3
Sell
1
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
515.4M
Book Value
8.55
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
1.37
PE Ratio
4.3066
Wall Street Target Price
7.5

Valuation

Trailing PE4.31
Forward PE0.0
Price/Sales (ttm)
1.47
Price/Book (mrq)
0.69
Enterprise Value
-274176270
Enterprise Value/Revenue
0.65
Enterprise Value/Ebitda
3.58

Technicals

50 Day MA
6.45
200 Day MA
15.72

Institutional Holdings

FMR Inc

14.94%

RA Capital Management, LLC

6.53%

Vanguard Group Inc

6.23%

Cormorant Asset Management, LLC

5.93%

Bain Capital Life Sciences Investors, LLC

4.45%

Perceptive Advisors LLC

2.72%

Discover more

Frequently Asked Questions

What is Atea Pharmaceuticals Inc share price today?

Can Indians buy Atea Pharmaceuticals Inc shares?

How can I buy Atea Pharmaceuticals Inc shares from India?

Can Fractional shares of Atea Pharmaceuticals Inc be purchased?

What are the documents required to start investing in Atea Pharmaceuticals Inc stocks?

What are today’s High and Low prices of Atea Pharmaceuticals Inc?

What are today’s traded volumes of Atea Pharmaceuticals Inc?

What is today’s market capitalisation of Atea Pharmaceuticals Inc?

What is the 52 Week High and Low Range of Atea Pharmaceuticals Inc?

How much percentage Atea Pharmaceuticals Inc is down from its 52 Week High?

How much percentage Atea Pharmaceuticals Inc is up from its 52 Week low?

What are the historical returns of Atea Pharmaceuticals Inc?

Who is the Chief Executive Officer (CEO) of Atea Pharmaceuticals Inc?